Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTHYF: Folinic Acid and Thyroid Hormone in Down Syndrome
NCT01576705Phase 3Completed
- Sponsor
- Institut Jérôme Lejeune
- Start
- Apr 2012
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of levothyroxine sodium, folinic acid in Down syndrome, sponsored by Institut Jérôme Lejeune. Started Apr 2012; status: completed.
02
Drugs
levothyroxine sodiumfolinic acid
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT01576705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576705.